Ligand validation:4FXJ

PHE: PHENYLALANINE

PHE is a Ligand Of Interest in 4FXJ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4FXJ_PHE_B_602	35%	56%	0.228	0.919	0.74	0.97	1	2	0	0	100%	1
4FXJ_PHE_A_603	18%	55%	0.318	0.909	0.74	0.98	1	2	0	0	100%	1
4FXJ_PHE_C_602	11%	55%	0.358	0.874	0.74	0.98	1	2	0	0	100%	1
4FXJ_PHE_D_602	8%	55%	0.404	0.881	0.74	1	1	2	0	0	100%	1
6GG4_PHE_B_603	67%	61%	0.138	0.948	0.63	0.84	-	1	0	0	100%	1
5FII_PHE_C_901	95%	64%	0.068	0.973	0.58	0.78	-	1	0	0	100%	1
5DCB_PHE_D_405	94%	60%	0.073	0.97	0.92	0.61	1	-	0	0	100%	1
3DES_PHE_B_412	93%	67%	0.073	0.969	0.73	0.54	-	-	1	0	100%	1
8ZVH_PHE_A_302	92%	57%	0.064	0.956	0.39	1.22	-	2	0	0	100%	1
6YU3_PHE_A_703	92%	46%	0.088	0.98	1.15	0.95	1	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.